| For: | Huang CX, Zhou XD, Pan CQ, Zheng MH. Screening for metabolic dysfunction-associated fatty liver disease: Time to discard the emperor’s clothes of normal liver enzymes? World J Gastroenterol 2024; 30(22): 2839-2842 [PMID: 38947289 DOI: 10.3748/wjg.v30.i22.2839] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8470/full/v30/i22/2839.htm |
| Number | Citing Articles |
| 1 |
Can Huang, Meng Chen, Yanfang Sun, Lin Zhang, Wei Liu. Research trends on the quality of life in patients with metabolic dysfunction-associated fatty liver diseases: a scientific metrology study. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1689280
|
| 2 |
Yuan Wu, Jing Zhou, Jun Zhang, Hongshan Li. Cytokeratin 18 in nonalcoholic fatty liver disease: value and application. Expert Review of Molecular Diagnostics 2024; 24(11): 1009 doi: 10.1080/14737159.2024.2413941
|
